Marion E. Scoggins

Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline <i>BRCA</i> Pathogenic Variant

Jennifer K. Litton, Marion E. Scoggins, Kenneth R. Hess et al. · Journal of Clinical Oncology · 2019 · 187 citations · Full text

Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence

Gaiane M. Rauch, Brian P. Hobbs, Henry M. Kuerer et al. · Annals of Surgical Oncology · 2015 · 56 citations · Full text

Tumoral Pathology, Breast Oncology, Biologic Features +11

A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activity

Jennifer K. Litton, Marion E. Scoggins, David L. Ramírez et al. · npj Breast Cancer · 2017 · 56 citations · Full text

Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status

Gaiane M. Rauch, Henry M. Kuerer, Marion E. Scoggins et al. · Breast Cancer Research and Treatment · 2013 · 51 citations · Full text

Breast Oncology, Medicine, Gynecology +8

Correlation Between Sonographic Findings and Clinicopathologic and Biologic Features of Pure Ductal Carcinoma In Situ in 691 Patients

Marion E. Scoggins, Patricia S. Fox, Henry M. Kuerer et al. · American Journal of Roentgenology · 2015 · 44 citations